SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2aka'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MX1_C_THAC3_1
(LIVER
CARBOXYLESTERASE I)
2aka DYNAMIN-1
(Rattus
norvegicus)
5 / 12 THR B 205
VAL B 174
LEU B 134
LEU B 172
LEU B  71
None
1.15A 1mx1C-2akaB:
1.9
1mx1C-2akaB:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NNP_A_ROCA401_2
(PROTEASE)
2aka DYNAMIN-1
(Rattus
norvegicus)
5 / 11 LEU B  48
ILE B 204
GLY B 202
ILE B 201
VAL B  47
None
1.03A 2nnpB-2akaB:
undetectable
2nnpB-2akaB:
17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AQI_B_CHDB6_0
(FERROCHELATASE)
2aka DYNAMIN-1
(Rattus
norvegicus)
5 / 12 LEU B  48
SER B  45
PRO B  58
VAL B  64
VAL B  97
None
1.26A 3aqiB-2akaB:
undetectable
3aqiB-2akaB:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MTE_A_SAMA220_0
(16S RRNA METHYLASE)
2aka DYNAMIN-1
(Rattus
norvegicus)
5 / 12 GLY B 233
GLY B 273
ALA B 177
LEU B 268
LEU B 207
None
1.18A 3mteA-2akaB:
undetectable
3mteA-2akaB:
22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_B_017B200_1
(FIV PROTEASE)
2aka DYNAMIN-1
(Rattus
norvegicus)
5 / 10 LEU B 181
ALA B 186
ILE B 189
ILE B 201
LEU B 187
None
0.97A 3ogpA-2akaB:
undetectable
3ogpA-2akaB:
15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P2K_B_SAMB6735_0
(16S RRNA METHYLASE)
2aka DYNAMIN-1
(Rattus
norvegicus)
5 / 12 GLY B 233
GLY B 273
ALA B 177
LEU B 268
LEU B 207
None
1.11A 3p2kB-2akaB:
undetectable
3p2kB-2akaB:
24.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ROX_A_TEPA266_1
(APOLIPOPROTEIN
A-I-BINDING PROTEIN)
2aka DYNAMIN-1
(Rattus
norvegicus)
4 / 8 ALA B 190
VAL B 193
ASP B 194
LEU B 170
None
0.84A 3roxA-2akaB:
undetectable
3roxA-2akaB:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TKD_A_CYZA266_2
(GLUTAMATE RECEPTOR 2)
2aka DYNAMIN-1
(Rattus
norvegicus)
4 / 5 ILE B 152
PRO B 149
SER B 116
GLY B 114
None
0.98A 3tkdB-2akaB:
undetectable
3tkdB-2akaB:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TKD_B_CYZB267_1
(GLUTAMATE RECEPTOR 2)
2aka DYNAMIN-1
(Rattus
norvegicus)
4 / 5 ILE B 152
PRO B 149
SER B 116
GLY B 114
None
0.99A 3tkdA-2akaB:
undetectable
3tkdA-2akaB:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W1W_A_CHDA1502_0
(FERROCHELATASE,
MITOCHONDRIAL)
2aka DYNAMIN-1
(Rattus
norvegicus)
5 / 12 LEU B  48
SER B  45
PRO B  58
VAL B  64
VAL B  97
None
1.29A 3w1wA-2akaB:
undetectable
3w1wA-2akaB:
21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HNX_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)
2aka DYNAMIN-1
(Rattus
norvegicus)
5 / 12 VAL B  64
LEU B 134
THR B 133
PRO B  68
ARG B  67
None
1.37A 5hnxB-2akaB:
undetectable
5hnxB-2akaB:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JQ7_B_T0RB705_1
(ENVELOPE
GLYCOPROTEIN
1,ENVELOPE
GLYCOPROTEIN
1,ENVELOPE
GLYCOPROTEIN 1
ENVELOPE
GLYCOPROTEIN 2)
2aka DYNAMIN-1
(Rattus
norvegicus)
4 / 7 VAL B 124
ALA B  81
LEU B  71
LEU B  69
None
0.51A 5jq7A-2akaB:
undetectable
5jq7A-2akaB:
23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5K50_A_ACTA1403_0
(L-THREONINE
3-DEHYDROGENASE)
2aka DYNAMIN-1
(Rattus
norvegicus)
4 / 5 SER B 175
VAL B 174
GLY B  38
ALA B 186
None
1.06A 5k50A-2akaB:
undetectable
5k50A-2akaB:
23.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LUH_B_SRYB303_1
(STREPTOMYCIN
3''-ADENYLYLTRANSFER
ASE)
2aka DYNAMIN-1
(Rattus
norvegicus)
5 / 10 ASP B 194
ASP B  30
HIS B 288
ILE B 289
THR B 292
None
1.17A 5luhB-2akaB:
0.0
5luhB-2akaB:
16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)
2aka DYNAMIN-1
(Rattus
norvegicus)
5 / 12 LEU B 207
ASP B 215
LEU B 220
THR B 205
LEU B 187
None
1.20A 6b0lB-2akaB:
2.3
6b0lB-2akaB:
14.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FGD_A_ACTA807_0
(GEPHYRIN)
2aka DYNAMIN-1
(Rattus
norvegicus)
4 / 4 PRO B  58
LEU B  69
VAL B  97
ARG B  98
None
1.34A 6fgdA-2akaB:
0.0
6fgdA-2akaB:
20.41